Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rhythm Biosciences Ltd. ( (AU:RHY) ) has shared an update.
Rhythm Biosciences Ltd has issued 38,321,133 ordinary shares without disclosure under the Corporations Act, in compliance with relevant legal provisions. The company’s ColoSTAT® Test-Kit, a blood-based test for colorectal cancer detection, and geneType™ platform for genetic risk assessment, position Rhythm Biosciences to address growing demand in preventative healthcare and precision medicine markets.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is an Australian medical diagnostics company focused on developing simple and affordable blood tests for early cancer detection. Established in 2017 and headquartered in Melbourne, the company aims to improve patient outcomes and reduce the global cancer burden by working with global partners for the commercialisation and distribution of its solutions.
Average Trading Volume: 744,118
Technical Sentiment Signal: Buy
Current Market Cap: A$30.54M
Learn more about RHY stock on TipRanks’ Stock Analysis page.